发明名称 THERAPEUTIC AGENT FOR MENIERE'S DISEASE
摘要 <P>PROBLEM TO BE SOLVED: To develop a therapeutic agent exhibiting effects safely, surely and rapidly by elucidating the reasons of problems in that conventional therapeutic agents of meniere's disease are necessarily taken in a large amount, it takes a long time for exhibiting its effects and the agent is not suitable for the administration for a long period of time. Ž<P>SOLUTION: The adverse effects accompanying the large amount of administration of a principal agent are avoided by observing the effects of a sugar or a sugar alcohol which is the principal agent, in an internal ear at the both of the treated side and normal side, inhibiting the elevation of plasma osmotic pressure and plasma AVP (arginine vasopressin) and confirming the safe and sure exhibition of an endolymphatic hydrops decompression effect by reducing the amount of administration of the principal agent, which is considered as impossible until now. By adding a necessary minimum amount of polysaccharides for aiming at an antidiarrheal activity, and also eliminating additives not directly related to the treatment as much as possible, the sure exhibition of the effects of the principal agent is succeeded even if the principal agent is of a small amount. Ž<P>COPYRIGHT: (C)2010,JPO&INPIT Ž
申请公布号 JP2009256308(A) 申请公布日期 2009.11.05
申请号 JP20080231796 申请日期 2008.09.10
申请人 TAKEDA SETSUKO 发明人 TAKEDA SETSUKO
分类号 A61K31/047;A61K31/7004;A61P27/16 主分类号 A61K31/047
代理机构 代理人
主权项
地址